Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Boehringer backs gene therapy firm Eyevensys

Invests in French eye disease specialist

- PMLiVE

Sanofi supports Clexane with Spanish VTE apps

The free iPhone, iPad and Android apps are for healthcare professionals

- PMLiVE

EMA recommends heart risk restriction for Servier’s Protelos

Use of osteoporosis drug likely to be further tightened up

Bupa appoints chief risk officer

Gerry Kelly joins from Lloyds

The evolving landscape of medical education

With new stakeholders, multimedia channels and budget constraints, medical education is changing fast

- PMLiVE

BMS plans major expansion of Orencia plant

Will invest $250m in biologics manufacturing facility

- PMLiVE

Lilly “plans to axe a third of US sales reps”

Cuts come ahead of key patent expiries for Cymbalta and Evista

- PMLiVE

Sanofi’s four-strain flu vaccine Vaxigrip under review in EU

Pharma company also launches production of ingredient for malaria drug

Zosano appoints Chris Krueger as chief business officer

He joins from Ardea Biosciences

National Institute for Health and Care Excellence NICE logo

Cell Therapeutics fails to gain NICE backing for blood cancer drug

Watchdog says not enough evidence to show Pixuvri is more effective than current treatments

- PMLiVE

Emerging business models for pharma

The traditional hegemony of the old monolithic pharma company is beginning to give way to a new, more interconnected business structure

- PMLiVE

Accenture report captures industry’s multichannel priorities

New survey suggests US sales and marketing executives already revamping structure and delivery models

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links